AKT1 and gastric cancer: This study demonstrated that 6-gingerol improves gastric cancer cells’ susceptibility to the chemotherapy drug cisplatin, and the processes involved in migratory inhibition, suppression of invasion, and G1 phase arrest via the PI3K/AKT signaling pathway.